Latest News

• Gallbladder, Biliary Tract Events Increased With Liraglutide Post-hoc analysis from the LEADER trial explores the relevant factors and potential mechanisms.
  Medscape Medical News, August 2019
• Thyroid Function Test Abnormalities Linked to Preterm Birth Risk of very preterm birth is notably higher with isolated hypothyroxinemia and thyroid peroxidase-antibody positivity, a new analysis shows, but evidence is lacking on possible benefits of treatment.
  Medscape Medical News, August 2019
• Aerosols in e-Cigs Harm Vasculature, Even Without Nicotine The impact of vaping on long-term health is unknown, but inhaling aerosols from a nicotine-free e-cigarette produces a transient harmful effect on blood vessels, a study found.
  Medscape Medical News, August 2019
• Docs, Nurses Weigh in on Use of Terms 'Providers,' 'Consumers' A Medscape poll shows physicians are much more likely to find the term "provider" undesirable and much less likely to view patients as "consumers" than nurses/APRNs.
  Medscape Medical News, August 2019
• Crisis for Severe Malaria Treatment in United States The last stocks of the only FDA-approved injectable drug for severe malaria expired in April, compassionate access to the only alternative is at least 8 hours away, and hospitals need emergency plans.
  Medscape Medical News, August 2019
• PBMs Pass on Rebates to Part D Drug Plans: GAO The finding is relevant to the congressional debate over whether drug rebates should be passed on to consumers.
  Medscape Medical News, August 2019
• Anti-Migraine Drug Recalled Due to Potential Contamination The voluntary recall of eletriptan hydrobromide 40-mg tablets is due to potential contamination with Pseudomonas and Burkholderia bacteria, the manufacturer has announced.
  News Alerts, August 2019
• Choking Hazard: Another Reason to Skip Supplements Multivitamin and calcium supplements often lodged in older adults' throats, presenting a preventable choking hazard, a study found.
  Medscape Medical News, August 2019
• The Power of Flowers May Ease Fibromyalgia Symptoms The beneficial impact of floristry on pain and psychiatric symptoms may be due to a multistimulatory effect that involves different senses, researchers suggest.
  Medscape Medical News, August 2019
• Alert FDA Approves Upadacitinib (Rinvoq), New JAK Inhibitor for RA Upadacitinib is for adults with moderately to severely active rheumatoid arthritis who fail to respond adequately or are intolerant to methotrexate.
  FDA Approvals, August 2019
• Alert FDA Approves New Form of HF Device Therapy, the Barostim Neo
  FDA Approvals, August 2019
• As CBD Finds Small-town America, What Do We Tell Its Graying Users? Skyrocketing demand has outpaced research on cannabidiol, particularly the complexities of its cardiovascular effects, a critical issue for vulnerable older adults whose CBD use is surging.
  Medscape Medical News, August 2019
• Alert FDA Clears First Spinal Tether Device for Idiopathic Scoliosis The Tether Vertebral Body Tethering System from Zimmer Biomet Spine is intended to treat growing children and adolescents whose spinal curves fail to respond to conservative treatment like external bracing.
  FDA Approvals, August 2019
• At Top Medical Journals, Women Are Gaining Ground -- Slowly Although there has been some progress, a woman's name rarely sits atop the masthead of a major medical journal.
  Medscape Medical News, August 2019
• Nine Hospital Nurses Pregnant at Same Time Have Given Birth Nine labor and delivery nurses from Maine Medical Center in Portland who were all pregnant at the same time have all given birth to their babies.
  Medscape Medical News, August 2019
• Germline Genome Editing: International Commission Urges Caution The International Commission on the Clinical Use of Human Germline Genome Editing met for the first time this week and urged caution.
  Medscape Medical News, August 2019
• Global Measles Cases Nearly Tripled Since Last Year, WHO Says So far this year, the number of global measles cases is surging, reaching numbers that haven't been this high since 2006, according to WHO; measles vaccine uptake is also suboptimal.
  Medscape Medical News, August 2019
• Alert FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB Pretomanid is only the third approved TB drug in 40 years. A pivotal study shows the oral drug regimen has a success rate of 89% and treatment takes 6 months instead of the current 2 years.
  FDA Approvals, August 2019
• Good Sleep Plus Limits on Screen Time Help With Impulse Control The potential for positive change is high because few kids meet suggested sleep time and screen limits, a study found. Physicians can use the evidence to advise parents, the researchers say.
  Medscape Medical News, August 2019
• Is It Ethical to Use Medical Data Derived From Evil Sources? Some immoral experiments have produced valuable information.
  Medscape Reader Polls, August 2019